Feredix |
Dextran-coated SPION |
Liver, spleen, bone marrow imaging |
|
|
Discontinued (toxicity) |
[30] |
Magnablate |
Iron nanoparticles |
Thermal ablation |
|
Prostate cancer |
NCT02033447 |
[136] |
Feraheme/ferumoxytol |
Iron oxide-carboxymethyl dextran |
Monitor response to bevacizumab therapy |
|
Glioma |
NCT00769093 |
[124, 135] |
Iron oxide-carboxymethyl dextran |
Localize lymph node metastases |
|
Pancreatic cancer |
NCT00920023 |
[124, 135] |
Iron oxide-carboxymethyl dextran |
Detect recent myocardial infarction |
|
Myocardial infarction |
NCT01995799 |
[124, 135] |
Iron oxide-carboxymethyl dextran |
Vascular imaging |
|
Migraine |
NCT02549898 |
[124, 135] |
VEGF-165 peptide coupling |
Cardiovascular imaging/VEGF delivery |
HUVEC |
|
|
[85] |
Iron-oxide-semi-synthetic carbohydrate shell |
Iron deficiency anemia, chronic kidney disease |
|
i.v injection in patients |
NCT00233597 |
[126] |
Ferumoxide |
Iron oxide-dextran |
Labeling of inflammed cells |
|
MRI imaging of patient forearm |
NCT01169935 |
[88] |
FIONs |
PEG-phospholipid |
Pancreatic islet graft imaging |
|
Rat liver |
|
[173] |
Ferrotran® (Ferumoxtran-10) |
Iron oxide-dextran |
Prostrate cancer |
|
Lymph node imaging |
NCT04261777 |
[174] |
(Gal-PEI-SPIO) |
Galactose (Gal) and polyethylenimine (PEI)-modified MNP |
siRNA duplexes targeting c-Met
|
Hepa1–6 cells |
Hepatic tumor model in C57BL/6 mice |
|
[175] |
(ZnFe2O4-mSi)core nanoparticle |
Magnetic zinc-doped iron oxide with mesoporous silica shell |
let-7a microRNA + doxorubicin payload |
Hela cells |
Xenografted nude mice |
|
[21] |
Magnetic nanoparticle formulation (MNPF) |
beta-Cyclodextrin and PEI coated iron oxide core |
miR-145 delivery |
HPAF-II, AsPC-1 |
|
|
[176] |
MPEI-PEG-magnetic nanoparticles |
PEI and PEG coated iron oxide core |
miR-205 payload delivery |
C4–2, PC-3 cells |
|
|
[177] |
Fe3O4-SPION |
Folic acid (FA) + disulfide-(PEG)-conjugated (PEI) complexed |
MRI, siRNA delivery in gastric cancer |
SGC-7901 |
|
|
[178] |
SPION |
T40 dextran coated, epichlorohydrine stabilized |
MRI of lymph node, liver, intestine |
|
Pig model |
|
[179] |
PEI nanoparticle |
Fe3O4-PEG-LAC-chitosan functionalized |
Survivin-siRNA targeted delivery |
MCF-7, K562 cells |
|
|
[147, 180] |
SPION |
Gemcitabine (Gem)-loaded PLGA-PEG functionalized |
Targeted drug delivery |
MCF-7 |
|
|
[21] |
Iron oxide NP |
Chitosan coated, gemcitabine (Gem)-loaded |
Targeted drug delivery |
SKBR and MCF-7 |
|
|
[181] |
SPIONs |
Daunomycin-loaded |
Targeted drug delivery |
HeLa |
|
|
[182] |
PSMA targeted docetaxel-loaded |
Targeted delivery |
PC-3 |
|
|
[127] |
Ferumoxide |
Poly-l-lysine coated |
Magnetic targeting in stroke |
HB1.F3 |
Rat |
|
[183] |
Paramagnetic perfluorocarbon nanoparticle |
Fumagillin loaded, rapamycin loaded, PEG-PEI-gadolinium: ETPA conjugated |
αvβ3-integrin-targeted systemic delivery |
|
Rabbit |
|
[184, 185] |
Rapamycin loaded, PEG-PEI-gadolinium: ETPA conjugated |
avb3-targeted local catheter delivery |
|
Rabbit |
|
[185] |
IONPs |
Polyacrylic acid-co-maleic acid (PAM) coated |
tPA delivery |
HUVEC |
Rats, human blood |
|
[186–188] |
Amine PEG coated with BSA/ATF protein surface conjugation |
Urokinase delivery |
PANC02 |
Mice |
|
[189] |
Streptavidin-coated |
miRNA-141 detection |
|
Human serum |
|
[42, 190] |
Streptavidin coated biotin labeled |
miR-21 detection |
LC–ESI–MS-MS-based |
MCF-7 |
|
[191] |
EDT coated and DOX loaded |
miR-155 |
bEnd.3, MDCK-MDR, U251 |
|
|
[130] |
Streptavidin-coated and HepB Ab conjugated |
Electrochemical detection of HepB |
Sandwich ELISA-based |
|
|
[192] |
Streptavidin-coated and biotinylated HIV-DNA probe conjugate |
Viral detection |
Electrical impedence based |
|
|
[193] |
Streptavidin-coated |
miRNA detection (let-7b) |
SEM, DLS based characterization |
|
|
[194] |
Fe3O4-virus-magnetic-MIPs (virus-MMIPs) |
Green self-polymerization strategy using dopmaine imprinting |
Hep A virus detection |
CHO cells |
Human serum sample |
|
[195] |
Fe3O4 NPs |
PEI coated |
Genome editing by CRISPR/Cas9 |
HEK-293 cells |
|
|
[196] |
Superparamagnetic particles |
Tosyl group and Influenza protein coated |
Viral detection by immunomagnetic assay |
|
Saliva sample |
|
[197] |
Graphene oxide MNP |
Carboxyl group |
miR-122 |
Fluorescein-labeled HRP-CRET |
|
|
[198] |
Zinc ferrite (ZnFe) |
Silica coated and amino (–NH2) modified with carboxylic polymers |
SARS-CoV-2 RNA capture |
Automated in vitro RNA extraction |
|
|
[156] |
BNF-80 |
Coated with protein A and SARS-CoV-2 spike protein antibody |
SARS-CoV-2 (virus) detection |
Spectroscopy-based |
|
|
[10] |
Fe3O4 NPs |
Amino (–NH2) modified and poly amino coated to generate poly-NH2-MNPs |
SARS-CoV-2 RNA capture and detection |
Spectroscopy and qPCR-based |
Nasopharyngeal swab samples |
|
[157] |